Primary Relief— 510(k) K221425

Substantially Equivalent

Dyansys, Inc.

FDA 510(k) clearance K221425 for Primary Relief, Substantially Equivalent on 2022-09-13. Applicant: Dyansys, Inc..

Clearance details

Applicant: Dyansys, Inc.
Product code: Code NHI
Advisory panel: Neurology
Date received: 2022-05-16
Decision date: 2022-09-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Mateo, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.